Katerina Placek1, Lauren Massimo1, Christopher Olm1, Kylie Ternes1, Kim Firn1, Vivianna Van Deerlin1, Edward B Lee1, John Q Trojanowski1, Virginia M-Y Lee1, David Irwin1, Murray Grossman1, Corey T McMillan2. 1. From the Department of Neurology, Penn Frontotemporal Degeneration Center (K.P., L.M., C.O., K.T., K.F., D.I., M.G., C.T.M.), and Department of Pathology & Laboratory Medicine, Center for Neurodegenerative Disease Research (V.V.D., E.B.L., J.Q.T., V.M.-Y.L., D.I.), University of Pennsylvania, Philadelphia. 2. From the Department of Neurology, Penn Frontotemporal Degeneration Center (K.P., L.M., C.O., K.T., K.F., D.I., M.G., C.T.M.), and Department of Pathology & Laboratory Medicine, Center for Neurodegenerative Disease Research (V.V.D., E.B.L., J.Q.T., V.M.-Y.L., D.I.), University of Pennsylvania, Philadelphia. mcmillac@upenn.edu.
Abstract
OBJECTIVE: To evaluate if cognitive reserve (CR) contributes to interindividual differences in frontal gray matter density (GMD) and executive impairment that underlie heterogeneity in the disease course of confirmed frontotemporal lobar degeneration (FTLD) pathology. METHODS: Fifty-five patients with autopsy confirmation or a pathogenic mutation consistent with underlying tau (FTLD-tau) or TDP-43 (FTLD-TDP) pathology and 90 demographically comparable healthy controls were assessed with T1 MRI and neuropsychological measures (Mini-Mental State Examination, letter fluency, forward digit span, Rey complex figure, and Boston Naming Test). CR was indexed using a composite measure of education and occupation. We used t tests to identify reduced GMD in patients with FTLD relative to controls, regression analyses to relate reduced GMD to CR index, and correlations to relate regions of GMD associated with CR to performance on neuropsychological measures. RESULTS: Patients with FTLD demonstrated impairment on neuropsychological measures. Patients with FTLD exhibited reduced bilateral frontotemporal GMD relative to controls, consistent with the known anatomic distribution of FTLD pathology. Higher CR index was associated with superior letter fluency and with GMD in right dorsolateral prefrontal cortex, orbitofrontal cortex, rostral frontal cortex, and inferior frontal gyrus. Furthermore, we found that higher GMD in frontal regions associated with CR was associated with superior letter fluency. CONCLUSIONS: Executive control and verbal ability assessed by letter fluency in FTLD is mediated in part by CR and frontal GMD. The identification of factors influencing cognitive and anatomic heterogeneity in FTLD suggests that CR should be considered in symptom detection, prognosis, and treatment.
OBJECTIVE: To evaluate if cognitive reserve (CR) contributes to interindividual differences in frontal gray matter density (GMD) and executive impairment that underlie heterogeneity in the disease course of confirmed frontotemporal lobar degeneration (FTLD) pathology. METHODS: Fifty-five patients with autopsy confirmation or a pathogenic mutation consistent with underlying tau (FTLD-tau) or TDP-43 (FTLD-TDP) pathology and 90 demographically comparable healthy controls were assessed with T1 MRI and neuropsychological measures (Mini-Mental State Examination, letter fluency, forward digit span, Rey complex figure, and Boston Naming Test). CR was indexed using a composite measure of education and occupation. We used t tests to identify reduced GMD in patients with FTLD relative to controls, regression analyses to relate reduced GMD to CR index, and correlations to relate regions of GMD associated with CR to performance on neuropsychological measures. RESULTS: Patients with FTLD demonstrated impairment on neuropsychological measures. Patients with FTLD exhibited reduced bilateral frontotemporal GMD relative to controls, consistent with the known anatomic distribution of FTLD pathology. Higher CR index was associated with superior letter fluency and with GMD in right dorsolateral prefrontal cortex, orbitofrontal cortex, rostral frontal cortex, and inferior frontal gyrus. Furthermore, we found that higher GMD in frontal regions associated with CR was associated with superior letter fluency. CONCLUSIONS: Executive control and verbal ability assessed by letter fluency in FTLD is mediated in part by CR and frontal GMD. The identification of factors influencing cognitive and anatomic heterogeneity in FTLD suggests that CR should be considered in symptom detection, prognosis, and treatment.
Authors: R Nathan Spreng; Alexander Drzezga; Janine Diehl-Schmid; Alexander Kurz; Brian Levine; Robert Perneczky Journal: Neuropsychologia Date: 2011-09-21 Impact factor: 3.139
Authors: M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman Journal: Neurology Date: 2011-02-16 Impact factor: 9.910
Authors: Julene K Johnson; Janine Diehl; Mario F Mendez; John Neuhaus; Jill S Shapira; Mark Forman; Dennis J Chute; Erik D Roberson; Catherine Pace-Savitsky; Manuela Neumann; Tiffany W Chow; Howard J Rosen; Hans Forstl; Alexander Kurz; Bruce L Miller Journal: Arch Neurol Date: 2005-06
Authors: Mark S Forman; Jennifer Farmer; Julene K Johnson; Christopher M Clark; Steven E Arnold; H Branch Coslett; Anjan Chatterjee; Howard I Hurtig; Jason H Karlawish; Howard J Rosen; Vivianna Van Deerlin; Virginia M-Y Lee; Bruce L Miller; John Q Trojanowski; Murray Grossman Journal: Ann Neurol Date: 2006-06 Impact factor: 10.422
Authors: Michael J Strong; Gloria M Grace; Morris Freedman; Cathy Lomen-Hoerth; Susan Woolley; Laura H Goldstein; Jennifer Murphy; Christen Shoesmith; Jeffery Rosenfeld; P Nigel Leigh; Lucie Bruijn; Paul Ince; Denise Figlewicz Journal: Amyotroph Lateral Scler Date: 2009-06
Authors: Michael D Gallagher; Eunran Suh; Murray Grossman; Lauren Elman; Leo McCluskey; John C Van Swieten; Safa Al-Sarraj; Manuela Neumann; Ellen Gelpi; Bernardino Ghetti; Jonathan D Rohrer; Glenda Halliday; Christine Van Broeckhoven; Danielle Seilhean; Pamela J Shaw; Matthew P Frosch; Irina Alafuzoff; Anna Antonell; Nenad Bogdanovic; William Brooks; Nigel J Cairns; Johnathan Cooper-Knock; Carl Cotman; Patrick Cras; Marc Cruts; Peter P De Deyn; Charles DeCarli; Carol Dobson-Stone; Sebastiaan Engelborghs; Nick Fox; Douglas Galasko; Marla Gearing; Ilse Gijselinck; Jordan Grafman; Päivi Hartikainen; Kimmo J Hatanpaa; J Robin Highley; John Hodges; Christine Hulette; Paul G Ince; Lee-Way Jin; Janine Kirby; Julia Kofler; Jillian Kril; John B J Kwok; Allan Levey; Andrew Lieberman; Albert Llado; Jean-Jacques Martin; Eliezer Masliah; Christopher J McDermott; Ann McKee; Catriona McLean; Simon Mead; Carol A Miller; Josh Miller; David G Munoz; Jill Murrell; Henry Paulson; Olivier Piguet; Martin Rossor; Raquel Sanchez-Valle; Mary Sano; Julie Schneider; Lisa C Silbert; Salvatore Spina; Julie van der Zee; Tim Van Langenhove; Jason Warren; Stephen B Wharton; Charles L White; Randall L Woltjer; John Q Trojanowski; Virginia M Y Lee; Vivianna Van Deerlin; Alice S Chen-Plotkin Journal: Acta Neuropathol Date: 2014-01-19 Impact factor: 17.088
Authors: David J Irwin; Corey T McMillan; Sharon X Xie; Katya Rascovsky; Vivianna M Van Deerlin; H Branch Coslett; Roy Hamilton; Geoffrey K Aguirre; Edward B Lee; Virginia M Y Lee; John Q Trojanowski; Murray Grossman Journal: Brain Date: 2018-01-01 Impact factor: 13.501
Authors: Katerina Placek; G Michael Baer; Lauren Elman; Leo McCluskey; Laura Hennessy; Pilar M Ferraro; Edward B Lee; Virginia M Y Lee; John Q Trojanowski; Vivianna M Van Deerlin; Murray Grossman; David J Irwin; Corey T McMillan Journal: Neurobiol Aging Date: 2018-09-27 Impact factor: 4.673
Authors: Christopher A Olm; Corey T McMillan; David J Irwin; Vivianna M Van Deerlin; Philip A Cook; James C Gee; Murray Grossman Journal: Neuroimage Clin Date: 2018-05-15 Impact factor: 4.881
Authors: Su Hong Kim; Yae Ji Kim; Byung Hwa Lee; Peter Lee; Ji Hyung Park; Sang Won Seo; Yong Jeong Journal: Front Aging Neurosci Date: 2022-06-20 Impact factor: 5.702
Authors: A C van Loenhoud; C de Boer; K Wols; Y A Pijnenburg; A W Lemstra; F H Bouwman; N D Prins; P Scheltens; R Ossenkoppele; W M van der Flier Journal: Alzheimers Res Ther Date: 2019-12-27 Impact factor: 6.982